S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
EVFM · EVOFEM BIOSCIENCES INC COM PAR $0.0001
OTC MARKETS - BOATS Real Time Price • USD
$0.48
-0.14
(-22.83%)
● At close: August 10 at 4:00:00 PM EDT
$1.88
+1.40
(+292.26%)
Overnight:
3:57:53 PM EDT
DAY'S RANGE
$0.48
$0.45
$0.58
52-WEEK RANGE
$0.48
$0.00
$0.02
What's happening
- EVFM is down 22.83% today, trading at $0.48. — Live quote
- It's trading within 3% of its 52-week high ($0.02). (Finnhub fundamentals)
- Volume today (88,973) is well below its 3-month average of 221,430. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 1
Strong sell 2
Aggregate ratings for 2025-03-01 (6 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
EVFM
-33.68%
vs S&P 500
-46.46%
1-YEAR RETURN
EVFM
-35.71%
vs S&P 500
-50.28%
6-MONTH RETURN
EVFM
-29.21%
3-MONTH RETURN
EVFM
-21.25%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2025-01-26 (Q4 2024)
$-0.03
Est. $—
2024-01-26 (Q4 2023)
$-0.44
Est. $-0.62
BEAT +29.3%
2023-10-26 (Q3 2023)
$0.10
Est. $-0.06
BEAT +263.4%
2023-01-26 (Q4 2022)
$-38.75
Est. $-26.77
MISS -44.7%
Valuation Measures & Ratios
Enterprise Value4$51.7M
Forward P/E50.00
PEG Ratio6-0.00
Price / Sales (TTM1)0.05
Price / Book7145.42
EV4 / Revenue2.55
EV4 / EBITDA13.34
Profit Margin-84.69%
Operating Margin-27.45%
Return on Equity (ROE8)208.02%
Return on Assets (ROA9)-43.14%
Avg Volume (3M)221,430
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short10,049
Change from Prior Settlement-10.67%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -45.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -84.7%. Finnhub fundamentals ↗
- Trailing 52-week price return is -35.7%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on EVFM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $899.0K | $5.0M | $4.8M | $845.0K | $4.5M | $4.2M | $3.6M |
| Operating income | -$2.5M | -$4.6M | $951.0K | -$1.3M | $327.0K | -$2.4M | -$1.4M | -$2.8M |
| Net income | -$11.0M | -$5.5M | -$1.6M | -$1.8M | $956.0K | -$2.4M | $1.4M | -$4.8M |
| EPS (diluted) | $-0.08 | $-0.04 | $-0.01 | $-0.01 | $0.00 | $-0.02 | $0.00 | $-0.16 |
| EPS (basic) | $-0.08 | $-0.04 | $-0.01 | $-0.01 | $0.01 | $-0.02 | $0.02 | $-0.16 |
| Operating margin | -$95 | -$508 | $19 | -$26 | $39 | -$54 | -$33 | -$79 |
| Net margin | -$419 | -$608 | -$32 | -$37 | $113 | -$53 | $32 | -$133 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $7.5M | $7.4M | $20.3M | $13.8M | $14.4M | $12.9M | $23.8M | $23.9M |
| Total liabilities | $90.0M | $80.2M | $89.7M | $84.0M | $79.2M | $77.7M | $90.3M | $90.1M |
| Stockholders' equity | -$87.5M | -$77.6M | -$74.3M | -$75.1M | -$69.6M | -$69.6M | -$71.3M | -$70.9M |
| Total current assets | $6.1M | $6.1M | $15.3M | $7.9M | $9.0M | $5.9M | $13.6M | $8.6M |
| Total current liabilities | $88.6M | $78.8M | $84.8M | $78.2M | $73.9M | $70.9M | $80.4M | $76.3M |
| Cash & equivalents | — | $1.5M | $578.0K | — | — | $221.0K | $741.0K | — |
| Accounts receivable | $2.5M | $560.0K | $12.5M | $4.4M | $4.9M | $1.1M | $9.8M | $5.4M |
| Inventory | $2.2M | $1.9M | $1.1M | $1.7M | $1.9M | $2.3M | $1.6M | $1.5M |
| Other current assets | $177.0K | $281.0K | $55.0K | — | — | — | $175.0K | — |
| Property, plant & equipment | $412.0K | $416.0K | $418.0K | $420.0K | $424.0K | $429.0K | $458.0K | $1.2M |
| Intangible assets | $869.0K | $778.0K | $4.3M | $5.2M | $4.7M | $6.5M | $9.6M | $14.0M |
| Other non-current assets | $41.0K | $42.0K | $42.0K | $36.0K | $36.0K | $36.0K | $36.0K | $36.0K |
| Accounts payable | $12.2M | $12.0M | $13.2M | $11.6M | $12.3M | $11.2M | $16.2M | $16.9M |
| Accrued liabilities | $1.6M | $1.2M | $1.3M | $1.4M | $3.3M | $3.2M | $5.5M | $5.1M |
| Deferred revenue (current) | $377.0K | $402.0K | $402.0K | — | — | — | — | — |
| Short-term debt | $362.0K | — | $147.0K | $291.0K | $383.0K | — | $135.0K | $268.0K |
| Other current liabilities | $11.2M | $10.2M | $12.0M | $8.2M | $7.6M | $7.2M | $7.4M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $11.0K | $11.0K | $10.0K |
| Retained earnings | -$914.0M | -$902.9M | -$897.4M | -$900.2M | -$898.5M | -$896.7M | -$897.7M | -$894.6M |
| Accumulated other comprehensive income (loss) | -$5.4M | -$6.6M | -$8.8M | -$6.7M | -$2.6M | -$2.0M | -$2.6M | -$1.7M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.1M | $2.3M | $31.0K | $336.0K | -$2.9M | $560.0K | -$2.4M | -$459.0K |
| Investing cash flow | $0 | -$2.0K | -$3.0K | $0 | -$2.0K | -$57.0K | -$46.0K | -$509.0K |
| Financing cash flow | $1.0M | -$498.0K | -$290.0K | -$244.0K | $2.6M | -$135.0K | $2.5M | $998.0K |
| Free cash flow | -$3.1M | $2.3M | $28.0K | $336.0K | -$2.9M | — | -$2.4M | -$459.0K |
| Capital expenditures | $0 | $2.0K | $3.0K | $0 | $2.0K | — | $0 | $0 |
| Share-based compensation | $0 | $15.0K | $42.0K | $23.0K | $31.0K | $70.0K | $188.0K | $203.0K |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | $1.9M | -$11.9M | $8.0M | -$499.0K | $3.8M | -$8.7M | $4.4M | $776.0K |
| Change in inventory | $265.0K | $761.0K | -$25.0K | -$222.0K | -$357.0K | $864.0K | $177.0K | $403.0K |
| Change in accounts payable | $29.0K | -$1.6M | $1.5M | -$656.0K | $1.1M | -$1.8M | -$699.0K | $776.0K |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | $397.0K |
| Debt repaid | — | — | — | — | — | — | — | $262.0K |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.2M | $19.4M | $18.2M | $16.8M | — |
| Operating income | $3.4M | -$7.7M | -$17.8M | -$84.1M | -$166.8M |
| Net income | $391.0K | -$8.9M | $53.0M | -$76.7M | -$205.2M |
| EPS (diluted) | $0.00 | $-0.11 | $0.05 | $-167.42 | $-23.63 |
| EPS (basic) | $0.00 | $-0.11 | $10.36 | $-167.42 | $-23.63 |
| Operating margin | $17 | -$40 | -$98 | -$500 | — |
| Net margin | $2 | -$46 | $291 | -$456 | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $20.3M | $23.8M | $10.6M | $25.2M | $42.5M |
| Total liabilities | $89.7M | $90.3M | $72.5M | $97.0M | $142.1M |
| Stockholders' equity | -$74.3M | -$71.3M | -$66.5M | -$71.8M | -$104.3M |
| Total current assets | $15.3M | $13.6M | $9.2M | $12.7M | $30.1M |
| Total current liabilities | $84.8M | $80.4M | $72.5M | $93.8M | $137.7M |
| Cash & equivalents | $578.0K | $741.0K | — | $2.8M | $7.7M |
| Accounts receivable | $12.5M | $9.8M | $5.7M | $1.1M | $6.4M |
| Inventory | $1.1M | $1.6M | $1.7M | $5.4M | $7.7M |
| Other current assets | $55.0K | $175.0K | — | — | — |
| Property, plant & equipment | $418.0K | $458.0K | $1.2M | $3.9M | $5.8M |
| Intangible assets | $4.3M | $9.6M | — | — | — |
| Other non-current assets | $42.0K | $36.0K | $35.0K | $4.1M | $1.2M |
| Accounts payable | $13.2M | $16.2M | $17.0M | $15.0M | $10.3M |
| Accrued liabilities | $1.3M | $5.5M | $4.2M | $4.1M | $8.4M |
| Deferred revenue (current) | $402.0K | — | — | — | — |
| Short-term debt | $147.0K | $135.0K | — | — | — |
| Other current liabilities | $12.0M | $7.4M | $3.3M | $2.9M | $2.9M |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $13.0K | $11.0K | $2.0K | $12.0K | $16.0K |
| Retained earnings | -$897.4M | -$897.7M | -$888.7M | -$938.7M | -$860.7M |
| Accumulated other comprehensive income (loss) | -$8.8M | -$2.6M | -$849.0K | $49.5M | $5.1M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$2.0M | -$3.9M | -$9.0M | -$70.4M | -$146.7M |
| Investing cash flow | -$62.0K | -$569.0K | -$4.0K | -$341.0K | -$2.7M |
| Financing cash flow | $1.9M | $4.6M | $4.8M | $61.9M | $90.7M |
| Free cash flow | -$2.0M | -$3.9M | -$9.0M | -$70.8M | -$149.6M |
| Capital expenditures | $5.0K | $14.0K | $4.0K | $341.0K | $2.9M |
| Share-based compensation | $166.0K | $847.0K | $1.2M | $3.3M | $8.9M |
| Deferred income taxes | — | — | — | $0 | $0 |
| Change in accounts receivable | $2.6M | $4.1M | $4.6M | -$5.3M | $5.4M |
| Change in inventory | $260.0K | -$57.0K | -$2.1M | -$1.6M | $21.0K |
| Change in accounts payable | $182.0K | -$910.0K | $4.1M | $4.5M | -$4.0K |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | $18.0K | $0 |
| Debt issued | — | — | $5.6M | $11.5M | $0 |
| Debt repaid | — | — | $1.2M | $5.9M | $0 |
| Tax withholding on stock comp | — | — | — | $0 | $327.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding EVFM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2021-06-10 to 2024-01-12
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Zhang Yan | CFO | Open market sale | 2024-01-12 | 104 |
| Kamdar Kim P. | Director | Open market sale | 2023-12-21 | 10 |
| PELLETIER SAUNDRA L | Chief Executive Officer | Disposition to issuer | 2022-12-31 | 50,000 |
| Fitzpatrick Alexander A | General Counsel and Secretary | Grant / award | 2022-02-18 | 300,000 |
| File Justin J. | Chief Financial Officer | Grant / award | 2022-02-18 | 450,000 |
| Barrans Russell | Chief Commercial Officer | Tax withholding | 2021-07-08 | 19,998 |
| O'Brien Anthony Stephen | Director | Open market purchase | 2021-06-14 | 8,140 |
| Rarick Lisa Dale | Director | Open market purchase | 2021-06-11 | 5,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:23 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 8-K | 2026-10-09 | View on SEC.gov → |
| 2026-09-23 | 8-K | 2026-09-17 | View on SEC.gov → |
| 2026-08-14 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-20 | 8-K | 2026-07-20 | View on SEC.gov → |
| 2026-07-14 | 8-K | 2026-07-08 | View on SEC.gov → |
| 2026-05-18 | 8-K | 2026-05-18 | View on SEC.gov → |
| 2026-05-15 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-30 | 8-K | 2026-04-24 | View on SEC.gov → |
| 2026-04-16 | 8-K | 2026-04-10 | View on SEC.gov → |
| 2026-03-19 | 8-K | 2026-03-13 | View on SEC.gov → |
| 2026-03-11 | 8-K | 2026-03-11 | View on SEC.gov → |
| 2026-03-11 | 10-K | 2025-12-31 | View on SEC.gov → |
Recent news
Headlines about EVFM (EVOFEM BIOSCIENCES INC COM PAR $0.0001). Links open the publisher — we don’t host full articles.
-
EVFM 8-K & SEC Filings
Yahoo Finance · 2026-10-15 -
Evofem Biosciences Celebrates Shipment of Its 500,000th Unit of PHEXX®, Representing Hormone-Free Protection from Unintended Pregnancy for 6 Million Acts of Sex
Yahoo Finance · 2026-07-23 -
HUB Cyber Security Expands Into Women’s Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround
Yahoo Finance · 2026-07-01 -
Evofem Biosciences GAAP EPS of -$0.04, revenue of $0.9M
Seeking Alpha · 2026-05-18 -
Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE
Yahoo Finance · 2025-11-21 -
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update
Yahoo Finance · 2025-11-13
No headlines in this category right now — try “All”.